4Basaran M,Bavbdk ES,Sakar B,et al.Treatment of aggressive non-Hodgkin's lymphoma with dose-intensified epirubicin in combination of cyclophosphamide,vincristine,and prednisone (CEOP-100):aphase II study[J]. Am J Clin Oncol,2001,24(6) :570.
5Aviles A, Garcia EL, Fernandez R, et al. Combined therapy in the treatment of primary mediastinal B- cell lymphoma:conventional versus escalated chemotherapy[J].Ann Hematol,2002,81(7) :368.
6Zinzani PL, Tani M, Stefoni V, et al. Efficacy of vinorelbine ,epirubicin and prednisone combination regimen inpretreated elderly patients with aggressive non-Hodgkin's lymphoma [ J ].Haematologica, 2001,86(3) :287.
7Zinzani PL, Tani M, Stefoni V, et al. Efficacy of vinorelbine, epirubicin and prednisone combination regimen inpretreated elderly patients with aggressive non - Hodgkin' s lymphoma[J]. Haematologica, 2001, 86 (3): 287 -290.
8Basaran M, Bavbek ES, Sakar B, et al. Treatment of aggressive nonodgkin' s lymphoma with dose - intensified epirubicin in combination of cyclophosphamide, vincristine, and prednisone (CEOP- 100): aphase Ⅱstudy[J]. Am J Clin Oncol, 2001,24(6): 570 - 575.
9Lambertenghi Deliliers G, Butti C, Baldini L, et al. A cooperative study of epirubicin with cyclophosphamide, vincristine and prednisone (CEOP) in non - Hodgkin' s lymphoma[J]. Hematologica, 1995, 80(4): 318 - 324.
10Chim CS, Kwong YL, Lie AK, et al. CEOP treatment results and validity of the International Prognostic Index in Chinese patients with aggressive nonHodgkin's lymphoma[J]. Hematol Oncol, 1998, 16(3):117-123.
